New Tool May Help Pharmacists Improve Diabetes Therapy

June 3, 2019

A new electronic tool may help independent pharmacists identify gaps in therapy and make recommendations in alignment with ADA guidelines, according to a study published in the Journal of the American Pharmacists Association.

Pharmacists used the tool to assess the patient record for the presence of an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker (ACEI/ARB), aspirin, or a statin. Then the pharmacist would:


Pharmacists utilized the tool 788 times during a 50-day period, and nearly 20 percent of MTPs were resolved.

See the study.